Page last updated: 2024-08-18

pyridostigmine bromide and Cardiomyopathy, Chagas

pyridostigmine bromide has been researched along with Cardiomyopathy, Chagas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castro, RRT; da Nóbrega, ACL; Ferlin, EL; Moraes, RS; Porphirio, G; Ribeiro, JP; Xavier, SS	1

Trials

1 trial(s) available for pyridostigmine bromide and Cardiomyopathy, Chagas

Article	Year
Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease. Cardiovascular therapeutics, 2017, Volume: 35, Issue:5 Topics: Administration, Oral; Anti-Arrhythmia Agents; Asymptomatic Diseases; Brazil; Chagas Cardiomyopathy; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Pyridostigmine Bromide; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes	2017

Article

Year

Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.

Cardiovascular therapeutics, 2017, Volume: 35, Issue:5

Topics: Administration, Oral; Anti-Arrhythmia Agents; Asymptomatic Diseases; Brazil; Chagas Cardiomyopathy; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Pyridostigmine Bromide; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes

2017